ID   COG-LY-357h
AC   CVCL_D5J5
DR   Wikidata; Q127380588
RX   PubMed=28119491;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 12,21
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M166 ! COG-LL-384h
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
RX   PubMed=28119491; DOI=10.1158/1535-7163.MCT-16-0749;
RA   Makena, Monish Ram
RA   Koneru, Balakrishna
RA   Nguyen, Thinh H.
RA   Kang, Min H.
RA   Reynolds, Charles Patrick
RT   "Reactive oxygen species-mediated synergism of fenretinide and
RT   romidepsin in preclinical models of T-cell lymphoid malignancies.";
RL   Mol. Cancer Ther. 16:649-661(2017).
//